What's breaking now, across thousands of outlets.
Merck’s ophthalmology candidate, remigromig, met the primary endpoint in a pivotal study, but the full results raise questions about the drug’s commercial prospects. Merck said last month that remigromig was non-inferior to ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Mumbai: The Food and Drug Administration (FDA) has suspended the food licence of Brijwasi’s operator, Krishnam Retails LLP, in Malad West, with immediate effect after an inspection allegedly revealed…
Maharashtra FDA chief Tukaram Mundhe denied reports that he had been transferred, saying he remains commissioner and will continue efforts against unsafe food and substandard drugs.
Long-term tracking of nearly 160,000 people from across the United States suggests that brain cancer risk rises as exposure to radon increases.
Dr. Ouma Oluga calls for data-driven HPT management, stronger hospital–KEMSA collaboration and greater accountability to improve essential health products availability.
Dr. Ouma Oluga calls for data-driven HPT management, stronger hospital–KEMSA collaboration and greater accountability to improve essential health products availability.
